Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Am J Geriatr Psychiatry ; 22(5): 427-36, 2014 May.
Article in English | MEDLINE | ID: mdl-23933423

ABSTRACT

OBJECTIVES: The population of older patients with schizophrenia is increasing. This study describes health outcomes, utilization, and costs over 10 years in a sample of older patients with schizophrenia compared with older patients without schizophrenia. METHODS: An observational cohort study of 31,588 older adults (mean age: 70.44 years) receiving care from an urban public health system, including a community mental health center, during 1999-2008. Of these, 1,635 (5.2%) were diagnosed with schizophrenia and 757 (2.4%) had this diagnosis confirmed in the community mental health center. Patients' electronic medical records were merged with Medicare claims, Medicaid claims, the Minimum Dataset, and the Outcome and Assessment Information Set. Information on medication use was not available. MEASUREMENTS: Rates of comorbid conditions, healthcare utilization, costs, and mortality. RESULTS: Patients with schizophrenia had significantly higher rates of congestive heart failure (45.05% versus 38.84%), chronic obstructive pulmonary disease (52.71% versus 41.41%), and hypothyroidism (36.72% versus 26.73%) than the patients without schizophrenia (p <0.001). They had significantly lower rates of cancer (30.78% versus 43.18%) and significantly higher rates of dementia (64.46% versus 32.13%). The patients with schizophrenia had significantly higher mortality risk (hazard ratio: 1.25, 95% confidence interval: 1.07-1.47) than the patients without schizophrenia. They also had significantly higher rates of healthcare utilization. The mean costs for Medicare and Medicaid were significantly higher for the patients with schizophrenia than for the patients without schizophrenia. CONCLUSIONS: The management of older adult patients with schizophrenia is creating a serious burden for our healthcare system, requiring the development of integrated models of healthcare.


Subject(s)
Continuity of Patient Care/economics , Continuity of Patient Care/statistics & numerical data , Health Care Costs/statistics & numerical data , Health Services for the Aged/economics , Health Services for the Aged/statistics & numerical data , Mental Health Services/economics , Mental Health Services/statistics & numerical data , Schizophrenia/economics , Age of Onset , Aged , Case-Control Studies , Cohort Studies , Comorbidity , Female , Health Services for the Aged/trends , Health Status , Humans , Male , Medicaid/economics , Medical Records , Medicare/economics , Schizophrenia/epidemiology , Schizophrenia/mortality , United States/epidemiology
2.
J Eval Clin Pract ; 14(5): 854-60, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19018918

ABSTRACT

RATIONALE, AIMS AND OBJECTIVES: Evidence suggests that educational outreach ('academic detailing') improves evidence-based prescribing. We evaluated the impact of an academic detailing programme intended to increase new statin prescriptions. METHODS: In a 2 x 2 factorial design we evaluated the effect of an academic detailing programme with/without telephonic care management for patients. Eligible patients were continuously enrolled Medicaid members at high risk for cardiovascular disease utilization who were not receiving statin medication in the 18 months prior to the intervention. All primary care prescribers assigned to these patients were randomized by clinic to academic detailing. Two trained nurses provided the detailing to prescribers, including specific discussion about the use of statins in this high-risk patient population. Nurses left the prescribers with a summary of clinical practice guidelines, a one-page detailing sheet and a list of patients under the care of the prescriber who were candidates for statins. The primary outcome was the incidence of a new statin prescription claim during the 6-month intervention period and the subsequent 6 months. Logistic regression models were used to estimate main effects of the interventions and to adjust for potential confounding variables in the study. RESULTS: Forty-eight clinics were randomized, effectively randomizing a total of 284 patients and 128 prescribers. Among the 284 patients, 46 (16%) received a new statin claim during the evaluation period. Controlling for significant bivariate associations, the academic detailing intervention had no significant effect on new statin prescriptions compared with the control group (odds ratio = 0.8, 95% confidence interval: 0.4-1.6, P = 0.5). CONCLUSION: Among this Medicaid population at high risk for cardiovascular events, an academic detailing programme to increase statin prescriptions was not effective. To assist others to learn from our failed effort, we identify and discuss critical elements in the design and implementation of the programme that could account for these results.


Subject(s)
Drug Prescriptions/statistics & numerical data , Education, Medical, Continuing/organization & administration , Evidence-Based Medicine/education , Medicaid , Practice Patterns, Physicians'/organization & administration , Primary Health Care/organization & administration , Cardiovascular Diseases/prevention & control , Chi-Square Distribution , Diffusion of Innovation , Female , Guideline Adherence , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Indiana , Logistic Models , Male , Medicaid/organization & administration , Middle Aged , Multivariate Analysis , Practice Guidelines as Topic , Program Evaluation , Telephone , United States
3.
J Am Med Inform Assoc ; 10(4): 389-98, 2003.
Article in English | MEDLINE | ID: mdl-12668695

ABSTRACT

The authors describe a research group that supports the needs of investigators seeking data from an electronic medical record system. Since its creation in 1972, the Regenstrief Medical Records System has captured and stored more than 350 million discrete coded observations on two million patients. This repository has become a central data source for prospective and retrospective research. It is accessed by six data analysts--working closely with the institutional review board--who provide investigators with timely and accurate data while protecting patient and provider privacy and confidentiality. From January 1, 1999, to July 31, 2002, data analysts tracked their activities involving 47,559 hours of work predominantly for physicians (54%). While data retrieval (36%) and analysis (25%) were primary activities, data analysts also actively collaborated with researchers. Primary objectives of data provided to investigators were to address disease-specific (35.4%) and drug-related (12.2%) questions, support guideline implementation (13.1%), and probe various aspects of clinical epidemiology (5.7%). Outcomes of these endeavors included 117 grants (including 300,000 US dollars per year salary support for data analysts) and 139 papers in peer-reviewed journals by investigators who rated the support provided by data analysts as extremely valuable.


Subject(s)
Biomedical Research , Medical Informatics/organization & administration , Medical Records Systems, Computerized , Statistics as Topic/organization & administration , Data Collection , Epidemiology/organization & administration , Humans , Research Personnel
SELECTION OF CITATIONS
SEARCH DETAIL
...